Literature DB >> 22869117

Expression, crystallization and preliminary crystallographic data analysis of PigF, an O-methyltransferase from the prodigiosin-synthetic pathway in Serratia.

Shaowei Liu1, Tingting Ran, Xiang Shen, Langlai Xu, Weiwu Wang, Dongqing Xu.   

Abstract

Prodigiosin, which is a member of the prodiginines, is a red linear tripyrrole compound. A gene cluster for the biosynthesis of prodigiosin has been identified in Serratia and most genes in the cluster have been functionally assigned. A bifurcated biosynthetic pathway for prodigiosin has previously been determined. The last step in the biosynthetic pathway of 4-methoxy-2,2'-bipyrrole-5-carbaldehyde (MBC) is catalyzed by PigF, which transfers a methyl group to 4-hydroxy-2,2'-bipyrrole-5-carbaldehyde (HBC) to form the terminal product MBC, but its catalytic mechanism is not known. To elucidate its mechanism, recombinant PigF was purified and crystallized. The crystals belonged to space group P2(1), with unit-cell parameters a = 69.4, b = 52.4, c = 279.2 Å, β = 96.8°. The native crystals may contain six molecules in the asymmetric unit, with a V(M) of 2.17 Å(3) Da(-1) and a solvent content of 43.43%. A full data set was collected at 2.6 Å resolution using synchrotron radiation on beamline BL17U of Shanghai Synchrotron Radiation Facility (SSRF), People's Republic of China. Molecular replacement was unsuccessful. To solve the structure of PigF by experimental phasing, selenomethionine-derivativized protein crystals were prepared from a condition with 0.01 M spermidine as an additive. One crystal diffracted to 1.9 Å resolution and a full data set was collected on beamline BL17U at SSRF. The crystal belonged to space group P2(1), with unit-cell parameters a = 69.0, b = 52.9, c = 93.4 Å, β = 97.3°. Heavy-atom substructure determination and phasing by SAD clearly showed that the crystal contains two molecules in the asymmetric unit, with a V(M) of 2.19 Å(3) Da(-1) and a solvent content of 43.82%.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22869117      PMCID: PMC3412768          DOI: 10.1107/S1744309112024001

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  26 in total

1.  Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia.

Authors:  C Campàs; M Dalmau; B Montaner; M Barragán; B Bellosillo; D Colomer; G Pons; R Pérez-Tomás; J Gil
Journal:  Leukemia       Date:  2003-04       Impact factor: 11.528

2.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

3.  Cloning and expression in a heterologous host of the complete set of genes for biosynthesis of the Streptomyces coelicolor antibiotic undecylprodigiosin.

Authors:  F Malpartida; J Niemi; R Navarrete; D A Hopwood
Journal:  Gene       Date:  1990-09-01       Impact factor: 3.688

Review 4.  Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels.

Authors:  B Miroux; J E Walker
Journal:  J Mol Biol       Date:  1996-07-19       Impact factor: 5.469

5.  The Serratia gene cluster encoding biosynthesis of the red antibiotic, prodigiosin, shows species- and strain-dependent genome context variation.

Authors:  Abigail K P Harris; Neil R Williamson; Holly Slater; Anthony Cox; Sophia Abbasi; Ian Foulds; Henrik T Simonsen; Finian J Leeper; George P C Salmond
Journal:  Microbiology       Date:  2004-11       Impact factor: 2.777

Review 6.  The biosynthesis and regulation of bacterial prodiginines.

Authors:  Neil R Williamson; Peter C Fineran; Finian J Leeper; George P C Salmond
Journal:  Nat Rev Microbiol       Date:  2006-12       Impact factor: 60.633

7.  Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines.

Authors:  B Montaner; S Navarro; M Piqué; M Vilaseca; M Martinell; E Giralt; J Gil; R Pérez-Tomás
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

8.  Integration, scaling, space-group assignment and post-refinement.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

9.  Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin.

Authors:  G D Van Duyne; R F Standaert; P A Karplus; S L Schreiber; J Clardy
Journal:  J Mol Biol       Date:  1993-01-05       Impact factor: 5.469

10.  Genomic blueprint of Hahella chejuensis, a marine microbe producing an algicidal agent.

Authors:  Haeyoung Jeong; Joung Han Yim; Choonghwan Lee; Sang-Haeng Choi; Yon Kyoung Park; Sung Ho Yoon; Cheol-Goo Hur; Ho-Young Kang; Dockyu Kim; Hyun Hee Lee; Kyun Hyang Park; Seung-Hwan Park; Hong-Seog Park; Hong Kum Lee; Tae Kwang Oh; Jihyun F Kim
Journal:  Nucleic Acids Res       Date:  2005-12-13       Impact factor: 16.971

View more
  4 in total

1.  Expression, crystallization and preliminary crystallographic data analysis of PigI, a putative L-prolyl-AMP ligase from the prodigiosin synthetic pathway in Serratia.

Authors:  Ning Han; Tingting Ran; Xiangdi Lou; Yanyan Gao; Jianhua He; Lin Tang; Dongqing Xu; Weiwu Wang
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-04-17       Impact factor: 1.056

2.  Comparative genome analyses of Serratia marcescens FS14 reveals its high antagonistic potential.

Authors:  Pengpeng Li; Amy H Y Kwok; Jingwei Jiang; Tingting Ran; Dongqing Xu; Weiwu Wang; Frederick C Leung
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

3.  Biological Potential and Mechanism of Prodigiosin from Serratia marcescens Subsp. lawsoniana in Human Choriocarcinoma and Prostate Cancer Cell Lines.

Authors:  Dan Li; Jun Liu; Xin Wang; Di Kong; Wei Du; Hongbo Li; Chung-Yun Hse; Todd Shupe; Dongpo Zhou; Kai Zhao
Journal:  Int J Mol Sci       Date:  2018-11-04       Impact factor: 5.923

4.  Crystal structures of PigF, an O-methyltransferase involved in the prodigiosin synthetic pathway, reveal an induced-fit substrate-recognition mechanism.

Authors:  Shenshen Qiu; Dongqing Xu; Mengxue Xu; Huan Zhou; Ning Sun; Li Zhang; Mengmeng Zhao; Jianhua He; Tingting Ran; Bo Sun; Weiwu Wang
Journal:  IUCrJ       Date:  2022-03-01       Impact factor: 4.769

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.